Medical Journals

Impact of Basic Fgf Expression in Astrocytes on Dopamine Neuron Synaptic Function and Development.

Authors:
  • Forget Caroline
  • Stewart Jane
  • Trudeau Louis-Eric

From: Department of Pharmacology, Faculty of Medicine, Université de Montréal, C.P. 6128, Succursale Centre-Ville Montréal, Québec, Canada, H3C 3J7.

The European journal of neuroscience

  • Publish Date: Feb 2006
  • ISSN: 0953-816X
  • Volume: 23
  • Issue: 3
  • Pages: 608-16
  • Medium: Print
  • Language: English
  • Citation (JAMA): Forget Caroline, Stewart Jane, Trudeau Louis-Eric, et al. Impact of Basic Fgf Expression in Astrocytes on Dopamine Neuron Synaptic Function and Development.. Eur. J. Neurosci. Feb 2006;23:608-16

Abstract

Behavioural sensitization to amphetamine (AMPH) requires action of the drug in the ventral midbrain where dopamine (DA) neurons are located. In vivo studies suggest that AMPH sensitization requires enhanced expression of basic fibroblast growth factor (bFGF) in the nucleus of midbrain astrocytes. One idea is that the AMPH-induced increase in bFGF expression in astrocytes leads to enhanced secretion of this peptide and to long-term plasticity in DA neurons. To study directly the effects of astrocytic expression of bFGF on DA neurons, we established a cell-culture model of mesencephalic astrocytes and DA neurons. Immunolabelling showed that even in the absence of a pharmacological stimulus, the majority of mesencephalic astrocytes in culture express bFGF at a nuclear level. Arguing against the idea that bFGF was secreted, bFGF was undetectable in the extracellular medium (below 10 pg/mL). However, supplementing culture medium with exogenous bFGF at standard concentrations (20 ng/mL) led to a dramatic change in the morphology of astrocytes, increased spontaneous DA release, and inhibited synapse formation by individual DA neurons. RNA interference (siRNA) against bFGF mRNA, caused a reduction in DA release but produced no change in synaptic development. Together these data demonstrate that under basal conditions (in the absence of a pharmacological stimulus such as amphetamine) bFGF is not secreted even though there is abundant nuclear expression in astrocytes. The effects of bFGF seen here on DA neurons are thus likely to be mediated through more indirect glial-neuronal interactions, leading to enhanced DA release without a necessary change in synapse number.

Mesh Headings (Keywords): Animals, Animals, Newborn, Antibodies, Astrocytes, Blotting, Western, Brain, Cells, Cultured, Coculture Techniques, Dopamine, Enzyme-Linked Immunosorbent Assay, Fibroblast Growth Factor 2, Gene Expression, Immunohistochemistry, Microscopy, Confocal, Neurons, Potassium, RNA, Small Interfering, Rats, Rats, Sprague-Dawley, S100 Proteins, Synapses


Check for Full Text / PubMed Unique Identifier (PMID): 16487142


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.